Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IDNA vs. FTXH: which is better?

Bottom line

IDNA vs FTXH: the short answer

IDNA (iShares Genomics Immunology and Healthcare ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.

IDNA is cheaper at 0.47% vs 0.6% — a difference of $13 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs −4.8% for IDNA (reporting dates differ).

Updated Nov 19, 2026

IDNA vs FTXH side by side

IDNAFTXH
TypeETFETF
Fund familyiSharesFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.47%0.6%
Annual cost per $10k$47$60
10-yr cost on $10k (prospectus)$591—
Max front loadNoneNone
12b-1 fee0%0%
1-yr return−1.0%+24.0%
5-yr return (annualized)−4.8%+6.5%
10-yr return (annualized)——
Best quarter+41.9%+18.3%
Worst quarter−21.5%−17.4%
Net assets (fund)$190.9M$36.2M
Number of holdings6151
Portfolio turnover49%35%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIDNAFTXHDifference
2024−1.0%+3.0%−4.0%
2023−7.8%−1.4%−6.4%
2022−42.1%+2.5%−44.6%
2021−4.0%+6.1%−10.1%
2020+54.5%+10.9%+43.6%

Source: Fund prospectus bar charts

Holdings overlap

5 of IDNA's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingIDNAFTXH
Regeneron Pharmaceuticals, Inc.4.35%2.72%
Incyte Corporation4.23%2.39%
Merck & Co., Inc.3.91%7.07%
Vertex Pharmaceuticals Incorporated3.87%3.41%
Exelixis, Inc.3.65%1.72%

Source: SEC Form N-PORT

IDNA top 10

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Incyte Corporation — 4.23%
  8. Moderna, Inc. — 4.19%
  9. Takeda Pharmaceutical Company Limited — 4.05%
  10. Merck & Co., Inc. — 3.91%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between IDNA and FTXH?
IDNA (iShares Genomics Immunology and Healthcare ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared. IDNA is cheaper at 0.47% vs 0.6% — a difference of $13 a year per $10,000 invested.
Which is cheaper, IDNA or FTXH?
IDNA has the lower expense ratio (0.47%).
Should I own both IDNA and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.